Multi-Donor-Derived Approach Generating a Unique Phenotypic Profile of NK Cells that can Eliminate Solid Tumors
Time: 4:00 pm
day: Day 1 PM
Details:
- Understanding the scientific basis and mechanisms behind combining NK cells from multiple donors predefined HLA-C and KIRs genotypes into one product
- Highlighting key advantages of this approach including advanced NK education and license for kill
- Showcasing clinical data of this approach from three different clinical trials in patients with solid tumors
